DanCann Pharma A/S announced that the company has appointed Sarah Mai Lykke-Kjeldsen as new Chief Operating Officer. Sarah Mai Lykke-Kjeldsen will join DanCann Pharma on 1 April 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0546 DKK | +29.38% | -7.46% | +82.00% |
03-29 | Dancann Pharma Plans Up to DKK19 Million Rights Issue | MT |
02-28 | DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+82.00% | 1.32M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- DANCAN Stock
- News Dancann Pharma A/S
- DanCann Pharma A/S Appoints Sarah Mai Lykke-Kjeldsen as New Chief Operating Officer, Effective 1 April 2022